Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Operating Income: 2018-2024

Historic Operating Income for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$689.5 million.

  • Revolution Medicines' Operating Income fell 79.42% to -$315.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 58.77%. This contributed to the annual value of -$689.5 million for FY2024, which is 41.53% down from last year.
  • Latest data reveals that Revolution Medicines reported Operating Income of -$689.5 million as of FY2024, which was down 41.53% from -$487.2 million recorded in FY2023.
  • Over the past 5 years, Revolution Medicines' Operating Income peaked at -$110.7 million during FY2020, and registered a low of -$689.5 million during FY2024.
  • Its 3-year average for Operating Income is -$478.3 million, with a median of -$487.2 million in 2023.
  • Data for Revolution Medicines' Operating Income shows a maximum YoY crashed of 104.54% (in 2020) over the last 5 years.
  • Over the past 5 years, Revolution Medicines' Operating Income (Yearly) stood at -$110.7 million in 2020, then crashed by 69.84% to -$188.0 million in 2021, then plummeted by 37.38% to -$258.3 million in 2022, then tumbled by 88.63% to -$487.2 million in 2023, then plummeted by 41.53% to -$689.5 million in 2024.